Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bristol-Myers Squibb Co (BMY) vs LTC Properties Inc (LTC) Price & Performance

Bristol-Myers Squibb CoTrade
LTC Properties IncTrade

Price performance (Past 24H)

Key statistics

Bristol-Myers Squibb Co vs LTC Properties Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.41 (market cap $132.45B), while LTC Properties Inc trades at $38.12 (market cap $2.12B). The key difference: Bristol-Myers Squibb Co is far larger — about 62.5× LTC Properties Inc's market cap, and LTC Properties Inc pays the higher dividend (5.78%). Which is the better fit depends on your goals.

BMYLTC
Market Cap
$132.45B$2.12B
Sector
HealthReal Estate
52-Week High
$65.89$42.81
52-Week Low
$42.60$33.98
Enterprise Value
$166.44B$2.86B
Dividend Yield
3.89%5.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bristol-Myers Squibb Co

No Aura AI signal available yet.

LTC Properties Inc

LTC Properties trades at $39.85, up 1.01% today, with a bullish technical signal supported by moving averages. The REIT shows strong fundamentals with a 14.08 P/E ratio, 38.93% net income margin, and consistent dividend payments of $0.19 monthly. Recent acquisitions in seniors housing (SHOP) portfolio total $285 million year-to-date, driving revenue growth from $210M in 2024 to $263M in 2025. However, earnings misses in two of the last three quarters and rising debt-to-asset ratio to 42.64% warrant caution.

Outlook remains positive due to demographic tailwinds in senior housing and aggressive SHOP expansion, but investors face risks from execution challenges in acquisitions and interest rate sensitivity. Analyst consensus is mixed with 27% buy ratings versus 59% hold, suggesting cautious optimism amid transition phase.

Returns comparison

Trailing returns across standard periods

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Read more on BMY

About LTC Properties Inc

LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.

Read more on LTC